Prioritizing genomic variants pathogenicity via DNA, RNA, and protein-level features based on extreme gradient boosting
Human Genetics · 2025
DOI: 10.1007/s00439-024-02667-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Genetics, 2025. Verfasst von Maolin Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Data and Computer Science, Sun Yat-Sen University, Guangzhou, 510000, China. Hauptthemen laut MEDLINE: Genetic Variation, RNA, DNA, Genomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
Genetic diseases are mostly implicated with genetic variants, including missense, synonymous, non-sense, and copy number variants. These different kinds of variants are indicated to affect phenotypes in various ways from previous studies. It remains essential but challenging to understand the functional consequences of these genetic variants, especially the noncoding ones, due to the lack of corresponding annotations. While many computational methods have been proposed to identify the risk variants. Most of them have only curated DNA-level and protein-level annotations to predict the pathogenicity of the variants, and others have been restricted to missense variants exclusively. In this study, we have curated DNA-, RNA-, and protein-level features to discriminate disease-causing variants in both coding and noncoding regions, where the features of protein sequences and protein structures have been shown essential for analyzing missense variants in coding regions while the features related to RNA-splicing and RBP binding are significant for variants in noncoding regions and synonymous variants in coding regions. Through the integration of these features, we have formulated the Multi-level feature Genomic Variants Predictor (ML-GVP) using the gradient boosting tree. The method has been trained on more than 400,000 variants in the Sherloc-training set from the 6th critical assessment of genome interpretation with superior performance. The method is one of the two best-performing predictors on the blind test in the Sherloc assessment, and is further confirmed by another independent test dataset of de novo variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Data and Computer Science, Sun Yat-Sen University, Guangzhou, 510000, China.
- School of Data and Computer Science, Sun Yat-Sen University, Guangzhou, 510000, China. yangyd25@mail.sysu.edu.cn.
- Key Laboratory of Machine Intelligence and Advanced Computing (Sun Yat-Sen University), Ministry of Education, Guangzhou, China. yangyd25@mail.sysu.edu.cn.
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510000, China. zhaohy8@mail.sysu.edu.cn.
Förderung
- NHGRI NIH HHS
- National Natural Science Foundation of China
Zitieren
APA
Ding, M., Chen, K., Yang, Y., & Zhao, H. (2025). Prioritizing genomic variants pathogenicity via DNA, RNA, and protein-level features based on extreme gradient boosting. Human Genetics. https://doi.org/10.1007/s00439-024-02667-0
Vancouver
Ding M, Chen K, Yang Y, Zhao H. Prioritizing genomic variants pathogenicity via DNA, RNA, and protein-level features based on extreme gradient boosting. Human Genetics. 2025. doi:10.1007/s00439-024-02667-0
BibTeX
@article{Ding2025,
author = {Ding, Maolin and Chen, Ken and Yang, Yuedong and Zhao, Huiying},
title = {Prioritizing genomic variants pathogenicity via DNA, RNA, and protein-level features based on extreme gradient boosting},
journal = {Human Genetics},
year = {2025},
doi = {10.1007/s00439-024-02667-0}
}
EUVIMED